Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBT vs. BIB: which is better?

Bottom line

FBT vs BIB: the short answer

FBT (First Trust NYSE Arca Biotechnology Index Fund) and BIB (ProShares Ultra Nasdaq Biotechnology) are both etfs.

But BIB is far broader, holding 267 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.

FBT is cheaper at 0.55% vs 0.95% — a difference of $40 a year per $10,000 invested.

Over five years, FBT returned +4.3% a year vs −1.0% for BIB.

Updated Nov 19, 2026

FBT vs BIB side by side

FBTBIB
TypeETFETF
Fund familyFirst TrustProShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.55%0.95%
Annual cost per $10k$55$95
10-yr cost on $10k (prospectus)—$1,401
Max front loadNoneNone
12b-1 fee0%—
1-yr return+24.1%+59.3%
5-yr return (annualized)+4.3%−1.0%
10-yr return (annualized)+6.3%+1.4%
Best quarter+27.8%+56.2%
Worst quarter−22.5%−42.7%
Net assets (fund)$2.8B$73.7M
Number of holdings32267
Portfolio turnover37%29%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBTBIBDifference
2025+24.1%+59.3%−35.3%
2024+5.8%−10.0%+15.8%
2023+2.3%−1.3%+3.5%
2022−4.6%−28.6%+24.0%
2021−3.6%−5.9%+2.3%
2020+12.9%+39.7%−26.8%
2019+19.8%+45.5%−25.7%
2018−0.2%−24.4%+24.2%
2017+37.0%+40.8%−3.8%
2016−19.6%−44.2%+24.6%

Source: Fund prospectus bar charts

Holdings overlap

8 of FBT's top 25 holdings also appear in BIB's top 25.

Shared top holdings
HoldingFBTBIB
Illumina Inc3.92%1.25%
Biogen Inc3.37%1.44%
Incyte Corp3.18%0.97%
Argenx Se3.13%1.19%
Vertex Pharmaceuticals Inc3.07%4.65%
Amgen Inc2.78%4.48%
United Therapeutics Corp2.56%1.22%
Alnylam Pharmaceuticals Inc2.52%2.01%

Source: SEC Form N-PORT

FBT top 10

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Illumina Inc — 3.92%
  7. Krystal Biotech Inc — 3.87%
  8. Natera Inc — 3.79%
  9. Axsome Therapeutics Inc — 3.71%
  10. Neurocrine Biosciences Inc — 3.53%

BIB top 10

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Gilead Sciences, Inc. — 4.66%
  4. Vertex Pharmaceuticals, Inc. — 4.65%
  5. Amgen, Inc. — 4.48%
  6. N/a — 3.94%
  7. N/a — 3.26%
  8. Regeneron Pharmaceuticals, Inc. — 3.21%
  9. N/a — 2.62%
  10. Alnylam Pharmaceuticals, Inc. — 2.01%

FAQ

What is the difference between FBT and BIB?
FBT (First Trust NYSE Arca Biotechnology Index Fund) and BIB (ProShares Ultra Nasdaq Biotechnology) are both etfs. But BIB is far broader, holding 267 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.
Which is cheaper, FBT or BIB?
FBT has the lower expense ratio (0.55%).
Should I own both FBT and BIB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.